Updated Jul 16, 2026
Neal James R has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $4K. Historical track record: 4/5 stars across 3 tracked purchases.

| Role | Insider |
|---|---|
| Notability | 20/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★☆ (4/5) |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 10000% |
| 90-day win rate | 0% |
| Avg 5-day return | +636.43% |
| Avg 30-day return | +591.17% |
| Avg 90-day return | -1997.30% |
| Best 30-day return | +693.07% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | PCSA | Processa Pharmaceuticals, Inc. | M — Option exercise | 203 | — | |
| 2026-04-02 | PCSA | Processa Pharmaceuticals, Inc. | P — Open-market purchase | 789 | $2.54 | $2K |
| 2024-12-26 | AKTX | Akari Therapeutics Plc | A — Grant or award | 2.00M | $0.00 | $1K |
| 2024-11-18 | PKBO | Peak Bio, Inc. | D — Derivative transaction | 37.9K | — | |
| 2024-11-18 | PKBO | Peak Bio, Inc. | J — Other acquisition / disposition | 37.9K | — |
Neal James R is a corporate insider — currently tracked as Insider of Processa Pharmaceuticals, Inc. (PCSA). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 5 open-market purchases ($4K) and 0 open-market sales () across all tracked filings.
Across 3 tracked purchases, Neal James R averaged +591.2% avg 30-day return with a 10000% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Neal James R profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.